4//SEC Filing
STEINMETZ MICHAEL 4
Accession 0001209191-12-037223
CIK 0001339455other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 11:59 AM ET
Size
16.5 KB
Accession
0001209191-12-037223
Insider Transaction Report
Form 4
SIMON NICHOLAS J III
10% Owner
Transactions
- Sale
Common Stock
2012-07-03$0.29/sh−98,210$28,481→ 3,571,677 total(indirect: See Footnote) - Sale
Common Stock
2012-07-02$0.29/sh−80,348$23,301→ 3,669,887 total(indirect: See Footnote)
GADICKE ANSBERT
10% Owner
Transactions
- Sale
Common Stock
2012-07-02$0.29/sh−80,348$23,301→ 3,669,887 total(indirect: See Footnote) - Sale
Common Stock
2012-07-03$0.29/sh−98,210$28,481→ 3,571,677 total(indirect: See Footnote)
EVNIN LUKE
10% Owner
Transactions
- Sale
Common Stock
2012-07-02$0.29/sh−80,348$23,301→ 3,669,887 total(indirect: See Footnote) - Sale
Common Stock
2012-07-03$0.29/sh−98,210$28,481→ 3,571,677 total(indirect: See Footnote)
GALAKATOS NICHOLAS
10% Owner
Transactions
- Sale
Common Stock
2012-07-02$0.29/sh−80,348$23,301→ 3,669,887 total(indirect: See Footnote) - Sale
Common Stock
2012-07-03$0.29/sh−98,210$28,481→ 3,571,677 total(indirect: See Footnote)
HENNER DENNIS
10% Owner
Transactions
- Sale
Common Stock
2012-07-02$0.29/sh−80,348$23,301→ 3,669,887 total(indirect: See Footnote) - Sale
Common Stock
2012-07-03$0.29/sh−98,210$28,481→ 3,571,677 total(indirect: See Footnote)
STEINMETZ MICHAEL
10% Owner
Transactions
- Sale
Common Stock
2012-07-03$0.29/sh−98,210$28,481→ 3,571,677 total(indirect: See Footnote) - Sale
Common Stock
2012-07-02$0.29/sh−80,348$23,301→ 3,669,887 total(indirect: See Footnote)
WHEELER KURT
Director
Transactions
- Sale
Common Stock
2012-07-02$0.29/sh−80,348$23,301→ 3,669,887 total(indirect: See Footnote) - Sale
Common Stock
2012-07-03$0.29/sh−98,210$28,481→ 3,571,677 total(indirect: See Footnote)
Footnotes (4)
- [F1]The shares were sold as follows: 66,976 by MPM BioVentures III-QP, L.P. ("BV III QP"), 4,503 by MPM BioVentures III, L.P. ("BV III"), 1,186 by MPM Asset Management Investors 2005 BVIII LLC ("AM 2005"), 2,023 by MPM BioVentures III Parallel Fund, L.P. ("BV Parallel") and 5,660 by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV KG"). MPM BioVentures III GP, L.P. ("MPM III GP") and MPM BioVentures III LLC ("MPM III LLC") are the direct and indirect general partners of BV III QP, BV III, BV Parallel and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Nicholas Simon III, Michael Steinmetz and Kurt Wheeler are the Series A members of MPM III LLC and the managers of AM 2005.
- [F2]The shares are held as follows: 3,059,087 by BV III QP, 205,697 by BV III, 54,191 by AM 2005, 92,406 by BV Parallel and 258,506 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
- [F3]The shares were sold as follows: 81,865 by BV III QP, 5,505 by BV III, 1,449 by AM 2005, 2,473 by BV Parallel and 6,918 by BV KG.
- [F4]The shares are held as follows: 2,977,222 by BV III QP, 200,192 by BV III, 52,742 by AM 2005, 89,933 by BV Parallel and 251,588 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
Documents
Issuer
Somaxon Pharmaceuticals, Inc.
CIK 0001339455
Entity typeother
Related Parties
1- filerCIK 0001166285
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 11:59 AM ET
- Size
- 16.5 KB